However missing CD4 data and being anaemic at the time of switch were important predictors of drug substitution among patients initiated on AZT/ABC + 3TC + LPVr, indicating exacerbated or unresolved anaemia [16]. This evidence concerns the gene CD4 and anemia (phenotype).